May 15, 2026 Experience Oruka Therapeutics collaboration with Halozyme We advised Oruka Therapeutics on the transaction
May 14, 2026 Experience BBVA $2.25 billion contingent convertible securities and senior notes offerings We advised BBVA on its offerings
May 14, 2026 Experience Purdue Pharma completes chapter 11 restructuring We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
May 14, 2026 Experience Bolivia $1 billion sovereign bond issuance We advised Bolivia on the offering
May 14, 2026 Experience First Eagle Holdings $575 million debut senior secured notes offering We advised the initial purchasers on the high-yield notes offering
May 13, 2026 Experience Antares Capital closes $8.5 billion Senior Loan Fund III We advised Antares Capital on the formation, fundraise and related matters for Antares SLF III
May 13, 2026 Experience Las Vegas Sands $1 billion notes offering We advised the underwriters on the offering
May 13, 2026 Experience J&F $485 million exchange offer and consent solicitation We advised the dealer managers and solicitation agents on the exchange offer
May 13, 2026 Experience METiS TechBio HK$2.43 billion IPO We advised METiS TechBio on its IPO and HKEX listing